Search Results - jianhui+zhou

7 Results Sort By:
Allosteric Inhibitors of the Main Protease of SARS-CoV-2
In this report, the SARS-CoV-2 3CLpro was expressed and purified. By using a FRET-based enzymatic assay, the researchers have screened a library consisting of more than 300 different niclosamide derivatives and identified three molecules JMX0286, JMX0301, and JMX0941 as potent allosteric inhibitors against SARS-CoV-2 3CLpro, with IC50 values like that...
Published: 4/1/2024   |   Inventor(s): Hongmin Li, subodh samrat, Zhong Li, Jia Zhou, Jimin Xu
Keywords(s):  
Category(s): Technology Classifications, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Healthcare Portfolios, Technology Classifications > Healthcare Portfolios > Infectious Diseases
Systems and Methods for Analyzing Genetic Data for Assessment of Gene Regulatory Activity in Disease Prediciton, Diagnosis and Treatment
Systems and Methods for Analyzing Genetic Data for Assessment of Gene Regulatory Activity in Disease Prediction, Diagnosis and Treatment Princeton Docket # 21-3806 Sequence is at the basis of how the genome and its variations shape chromatin organization, regulate gene expression, and impact traits and diseases. Epigenomic profiling efforts have...
Published: 12/6/2023   |   Inventor(s): Olga Troyanskaya, Kathleen Chen, Jian Zhou
Keywords(s):  
Category(s): Biotechnology/Pharmaceuticals, Medical Devices/Diagnostics, Computer Science and Information Technology
Fast quantitative magnetization transfer imaging
[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 5 March 2021] We are inviting expressions of interest (EoI) for commercializing “Fast Quantitative Magnetization Transfer Imaging” technology. The innovation is developed by Professor Weitian CHEN, Professor of the Department of Imaging and Interventional...
Published: 1/10/2022   |   Inventor(s): Weitian CHEN, Jian HOU, Baiyan JIANG
Keywords(s):  
Category(s): Medical Imaging
DeepSEA and Seqweaver: Deep learning frameworks for the identification of de novo disease-causing mutations in noncoding sequences
DeepSEA and Seqweaver: Deep learning frameworks for the identification of de novo disease-causing mutations in noncoding sequencesPrinceton Docket #s 18-3426, 18-3440Researchers at Princeton University and Rockefeller University have collaborated to establish methods for the identification of de novo mutations in the vast noncoding genomic sequences....
Published: 4/23/2024   |   Inventor(s): Jian Zhou, Olga Troyanskaya, Christopher Park, Robert Darnell, Chandra Theesfeld
Keywords(s):  
Category(s): Computer Science and Information Technology
Predicting Genomic Variation Effects on Human Gene Transcription
De novo prediction of tissue-specific expression effect and disease risk for every mutation in a human genome - ExpectoPrinceton Docket # 18-3423Sequence-based models, with their scalability and usage of sequence dependencies, enable a new era of mutation analysis at unprecedented scale that can yield a new perspective on human variation in human diseases...
Published: 9/26/2022   |   Inventor(s): Olga Troyanskaya, Jian Zhou, Chandra Theesfeld
Keywords(s):  
Category(s): Biotechnology/Pharmaceuticals, Computer Science and Information Technology
Bi-Functional RGD Peptide and a Co-Signaling Mechanism to Promote Therapeutic Angiogenesis
Bi-Functional RGD Peptide to Promote Therapeutic Angiogenesis, Treat Ischemic Diseases Technology: While previous studies have focused on the identification of biological ligands to improve the functions of endothelial cells, MUSC and Clemson University researchers have combined modern bioinformatics and a newly established peptide functionalized...
Published: 3/23/2023   |   Inventor(s): Chung-Jen (James) Chou, Ying Mei, Jia Jia
Keywords(s):  
Category(s): BioPharma
Compositions and Methods for the Modulation of Sphingolipid Metabolism and/or Signaling
Technology Number: CH-009 IP Status: Patent issued, available for exclusive field of use or non-exclusive licensing Inventor: Dr. Julie D. Saba and Dr. Henrik Fyrst Background: Breast cancer is the most common form of cancer and remains the second leading cause of cancer death in American women, despite advances in both detection and treatment....
Published: 7/30/2020   |   Inventor(s): Julie Saba, Jianhui Zhou, Henrik Fyrst
Keywords(s):  
Category(s): Therapeutic, Research Tool